Find More Contacts for Thermalin
Protected Content
President
Executive Medical & Science
1 email found 1 phone number found
View contacts for Thermalin to access new leads and connect with decision-makers.
View All Contacts
  • Company Type For Profit
  • Contact Email rick@thermalin.com
  • Phone Number 617-695-0523

Thermalin hopes to disrupt the $30B insulin/insulin delivery market with a disposable, postage-stamp-sized glucose management system enabled by our first-in-class stabilized, highly concentrated, and ultra-rapid acting insulin. This same new insulin molecule in "ordinary" (U-100) concentration will enable the factory-filling of

reservoirs for existing insulin pumps. In addition to this lead program, Thermalin is developing partnerships on no-cold-chain basal and mix insulins and on glucose-responsive insulins.

Lists Featuring This Company

Life Science Companies With Less Than $10M in Revenue
3,779 Number of Organizations â€¢ $48.3B Total Funding Amount â€¢ 6,450 Number of Investors
Health Care Companies With Fewer Than 100 Employees (Top 10K)
9,971 Number of Organizations â€¢ $276.2B Total Funding Amount â€¢ 47,900 Number of Investors
Medical Companies With Less Than $1B in Revenue (Top 10K)
9,933 Number of Organizations â€¢ $375.7B Total Funding Amount â€¢ 27,357 Number of Investors
Midwestern US Companies With More Than $1M in Revenue (Top 10K)
9,715 Number of Organizations â€¢ $408.5B Total Funding Amount â€¢ 15,025 Number of Investors

Frequently Asked Questions

Where is Thermalin's headquarters? Thermalin is located in Cleveland, Ohio, United States.Who invested in Thermalin? Thermalin has 6 investors including Robin Hood Ventures and Robin Hood Ventures.How much funding has Thermalin raised to date? Thermalin has raised .When was the last funding round for Thermalin? Thermalin closed its last funding round on Aug 18, 2022 from a Venture - Series Unknown round.Who are Thermalin's competitors? Alternatives and possible competitors to Thermalin may include Enable InjectionsSemma Therapeutics, and Ontera.